Precision Medicine and Personalized Approach to Renal Transplantation

被引:6
作者
Dafoe, Donald C. [1 ]
Tantisattamo, Ekamol [2 ]
Reddy, Uttam [2 ]
机构
[1] Univ Calif Irvine, Dept Surg, Div Transplantat Surg, Sch Med, Irvine, CA 92717 USA
[2] Univ Calif Irvine, Sch Med, Dept Med, Div Nephrol & Hypertens, Irvine, CA 92717 USA
关键词
Renal transplantation; personalized care; transplant immunosuppression; precision medicine; SURVIVAL;
D O I
10.1016/j.semnephrol.2018.05.005
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Successful renal transplantation is a highly effective endeavor that improves and prolongs the lives of patients with chronic kidney disease. Transplant surgery and immunosuppression carries risk and the demand for donor kidneys outstrips supply by far. These realities mandate thoughtful allocation and utilization of this limited resource to select candidates. As the criteria for candidates and donor grafts continue to expand, the field must adapt and seek new approaches. The complex process from evaluation of candidates, transplant surgery, immunosuppression, and follow-up care after transplantation is, of necessity, tightly structured and regulated. However, each patient has distinctive characteristics that must be taken into account to optimize individual outcomes. The personalized approach to renal transplantation, which uses precision medicine concepts, identifies unique aspects of candidates/recipients that require consideration using a combination of time-honored guidelines, emerging concepts, new medications, and refinements of care. (C) 2018 Elsevier Inc. All rights reserved.
引用
收藏
页码:346 / 354
页数:9
相关论文
共 57 条
  • [1] Racial variation in dosage requirements of tacrolimus
    Andrews, PA
    Sen, M
    Chang, RWS
    [J]. LANCET, 1996, 348 (9039) : 1446 - 1446
  • [2] Establishing Biomarkers in Transplant Medicine: A Critical Review of Current Approaches
    Anglicheau, Dany
    Naesens, Maarten
    Essig, Marie
    Gwinner, Wilfried
    Marquet, Pierre
    [J]. TRANSPLANTATION, 2016, 100 (10) : 2024 - 2038
  • [3] [Anonymous], AM J TRANSPLANT S3
  • [4] [Anonymous], 2017 ANN REP US ORG
  • [5] Rabbit antithymocyte globulin versus basiliximab in renal transplantation
    Brennan, Daniel C.
    Daller, John A.
    Lake, Kathleen D.
    Cibrik, Diane
    Del Castillo, Domingo
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (19) : 1967 - 1977
  • [6] Predictable response: Finding optimal drugs and doses using artificial intelligence
    Chakradhar, Shraddha
    [J]. NATURE MEDICINE, 2017, 23 (11) : 1244 - 1247
  • [7] Living donor renal transplantation in patients with antiphospholipid syndrome A case report
    Choi, Ji Yoon
    Jung, Joo Hee
    Shin, Sung
    Kim, Young Hoon
    Han, Duck Jong
    [J]. MEDICINE, 2016, 95 (46)
  • [8] Chopra B, 2015, WORLD J TRANSPLANT, V2, P38
  • [9] Psychosocial health of living kidney donors: A systematic review
    Clemens, K. K.
    Thiessen-Philbrook, H.
    Parikh, C. R.
    Yang, R. C.
    Karley, M. L.
    Boudville, N.
    Prasad, G. V. Ramesh
    Garg, A. X.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2006, 6 (12) : 2965 - 2977
  • [10] Impact of de novo donor-specific HLA antibodies detected by Luminex solid-phase assay after transplantation in a group of 88 consecutive living-donor renal transplantations
    Dieplinger, Georg
    Ditt, Vanessa
    Arns, Wolfgang
    Huppertz, Andrea
    Kisner, Tuelay
    Hellmich, Martin
    Bauerfeind, Ursula
    Stippel, Dirk L.
    [J]. TRANSPLANT INTERNATIONAL, 2014, 27 (01) : 60 - 68